NTRB
Nutriband Inc.NASDAQHealthcare$3.63+2.75%ClosedMarket Cap: $44.2M
As of 2026-04-06
Valuation
P/E (TTM)
—
PEG
—
P/B
5.96
P/S
19.93
EV/EBITDA
-3.22
DCF Value
$-3.13
FCF Yield
-12.4%
Div Yield
0.0%
Margins & Returns
Gross Margin
32.6%
Operating Margin
-406.5%
Net Margin
-560.8%
ROE
-185.4%
ROA
-151.8%
ROIC
-118.6%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q3 2025 | $346.1K | 19.8% | $-3.9M | $-3.9M | $-0.32 | — |
| Q2 2025 | $622.5K | 25.2% | $-2.0M | $-2.0M | $-2.12 | — |
| Q1 2025 | $667.4K | 36.5% | $-1.4M | $-1.4M | $-0.12 | — |
| Q4 2024 | $642.4K | 42.8% | $-2.0M | $-5.5M | $-0.51 | — |
| FY 2024 | $2.1M | 32.7% | $-6.7M | $-10.5M | $-0.99 | — |
| Q3 2024 | $645.8K | 27.8% | $-1.4M | $-1.4M | $-0.12 | — |
| Q2 2024 | $442.8K | 20.5% | $-1.4M | $-1.7M | $-0.15 | — |
| Q1 2024 | $408.5K | 37.7% | $-1.9M | $-1.9M | $-0.21 | — |
| Q4 2023 | $524.6K | 32.4% | $-1.3M | $-1.9M | $-0.23 | — |
| FY 2023 | $2.1M | 41.3% | $-4.9M | $-5.5M | $-0.69 | — |
| Q3 2023 | $427.8K | 37.1% | $-1.7M | $-1.8M | $-0.22 | — |
| Q2 2023 | $655.9K | 45.7% | $-824.2K | $-829.2K | $-0.11 | — |